A cross-sectional study on skin cancer screening behaviors in sexual minorities among adults in the United States

Rypka, Katelyn J.; Jacobsen, Audrey A.; Mansh, Matthew

doi:10.1016/j.jaad.2023.04.060

Cited by 3 publications

(3 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Limited health care access, coverage, and financial limitations among bisexual women may influence their awareness and/or behaviors related to skin cancer risk factors . Finally, observed differences could be related to detection bias as prior studies found that SM males are more likely than heterosexual males to obtain skin cancer screening …”

Section: Discussionmentioning

confidence: 99%

“…14 Finally, observed differences could be related to detection bias as prior studies found that SM males are more likely than heterosexual males to obtain skin cancer screening. 4,15 Limitations Study limitations include sampling and nonresponse bias as some US states or territories were excluded due to lack of data collection on sexual orientation (eTable 1 in Supplement 1). Furthermore, skin cancer outcomes were selfreported without medical record review or histopathologic confirmation.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Sexual Orientation and Lifetime Prevalence of Skin Cancer Across Racial and Ethnic Groups

Rypka,

Wendland,

Steele

et al. 2024

JAMA Dermatol

View full text Add to dashboard Cite

ImportanceSexual minority (SM) persons have been found to have differential rates of skin cancer, but limited data exist on differences across racial and ethnic groups and by individual sexual identities.ObjectiveTo examine differences by sexual orientation in the lifetime prevalence of skin cancer among US adult females and males across racial and ethnic groups and by individual sexual identity.Design, Setting, and ParticipantsThis cross-sectional study used data from the Behavioral Risk Factor Surveillance System from January 1, 2014, to December 31, 2021, for US adults from the general population. Data were analyzed from December 1, 2023, to March 1, 2024.Main Outcomes and MeasuresSelf-reported lifetime prevalence of skin cancer by sexual orientation. Age-adjusted prevalence and adjusted prevalence odds ratios (AORs) compared heterosexual and SM adults in analyses stratified by individual race.ResultsOf 1 512 400 participants studied, 805 161 (53.2%) were heterosexual females; 38 933 (2.6%), SM females; 638 651 (42.2%), heterosexual males; and 29 655 (2.0%), SM males. A total of 6.6% of participants were Hispanic; 3.4%, non-Hispanic Asian, Pacific Islander, or Hawaiian; 7.5%, non-Hispanic Black; 78.2%, non-Hispanic White; and 4.3%, other race and ethnicity. Mean (SE) age was 48.5 (0.03) years (incomplete data for age of respondents ≥80 years). The lifetime prevalence of skin cancer was overall higher among SM males compared with heterosexual males (7.4% vs 6.8%; AOR, 1.16; 95% CI, 1.02-1.33), including specifically among Hispanic males (4.0% vs 1.6%; AOR, 3.81; 95% CI, 1.96-7.41) and non-Hispanic Black males (1.0% vs 0.5%; AOR, 2.18; 95% CI, 1.13-4.19) in analyses stratified by race and ethnicity. Lifetime prevalence rates were lower among SM females compared with heterosexual females among non-Hispanic White females (7.8% vs 8.5%; AOR, 0.86; 95% CI, 0.76-0.97) and were higher among Hispanic (2.1% vs 1.8%; AOR, 2.46; 95% CI, 1.28-4.70) and non-Hispanic Black (1.8% vs 0.5%; AOR, 2.33; 95% CI, 1.01-5.54) females in analyses stratified by race and ethnicity.Conclusions and RelevanceIn this cross-sectional study of US adults, differences in the lifetime prevalence of skin cancer among SM adults compared with heterosexual adults differed across racial and ethnic groups and by individual sexual identity among both females and males. Both Hispanic and non-Hispanic Black and SM females and males had higher rates of skin cancer compared with their heterosexual counterparts. Further research addressing the individual factors contributing to these differences is needed to inform screening guidelines and public health interventions focused on these diverse, heterogeneous populations.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Sexual Orientation and Lifetime Prevalence of Skin Cancer Across Racial and Ethnic Groups

Rypka,

Wendland,

Steele

et al. 2024

JAMA Dermatol

View full text Add to dashboard Cite

show abstract

“…Full-body skin examinations (FBSEs) are key tools for skin cancer prevention and are recommended for at-risk individuals . Limited research has evaluated FBSEs in sexual and gender minority (SGM) patients; 2 studies found higher rates of FBSEs among sexual minority individuals compared with heterosexual individuals . However, data on gender minority patients are lacking, and their experiences with FBSEs are incompletely understood.…”

mentioning

confidence: 99%

Perspectives on Full-Body Skin Examinations Among Sexual and Gender Minority Patients

Verghese,

Freeman,

Connor

et al. 2024

JAMA Dermatol

View full text Add to dashboard Cite

show abstract

Burden of melanoma in China and its provinces from 1990 to 2021: an analysis for the Global Burden of Disease Study 2021

Yu,

Yan,

et al. 2024

Front. Public Health

View full text Add to dashboard Cite

BackgroundThe incidence of melanoma in China has been increasing over the past few decades. This study aimed to investigate the burden of melanoma at both national and subnational level in China, where the population is rapidly aging.MethodsThe annual melanoma data from 1990 to 2021 was collected from the Global Burden of Disease (GBD) 2021 China subnational study. Number of cases and age-standardized rates were estimated for incidence, mortality, prevalence, disability-adjusted life-years (DALYs) of melanoma by age and sex at subnational level with 33 province-level administrative units. Joinpoint regression model was used to evaluate the trends in disease burdens attributable to melanoma across time. A decomposition method was used to attribute changes in total deaths and DALYs to three explanatory components: population growth, population aging, and change of age-specific rates.ResultsOver the past 30 years, the age-standardized incidence rate (ASIR) of melanoma in China has shown an upward trend. The ASIR of melanoma in 2021 was 0.7 per 100,000 (95%UI 0.4–0.9), representing an increase of 89.2% (95% UI: 14.7–157.9%) from 1990. Among younger adults aged <60 years, melanoma was more common in men, whereas among older adults who were aged >60 years, it was more common in women. The ASIR was higher in the coastal provinces in 2021 and the age-standardized rates (ASR) of DALYs was generally higher in the western provinces. Total numbers of death and DALYs of melanoma increased over the study period, mainly driven by population aging in China.ConclusionChina has experienced a substantial increase in the burden of melanoma from 1990 to 2021. It is beneficial to develop more targeted strategies for older adults populations, especially for women, to reduce the melanoma burden throughout China, particularly in some coastal and western provinces.

show abstract

A cross-sectional study on skin cancer screening behaviors in sexual minorities among adults in the United States

Cited by 3 publications

References 4 publications

Sexual Orientation and Lifetime Prevalence of Skin Cancer Across Racial and Ethnic Groups

Sexual Orientation and Lifetime Prevalence of Skin Cancer Across Racial and Ethnic Groups

Perspectives on Full-Body Skin Examinations Among Sexual and Gender Minority Patients

Burden of melanoma in China and its provinces from 1990 to 2021: an analysis for the Global Burden of Disease Study 2021

Contact Info

Product

Resources

About